Free shipping on all orders over $ 500

LY3499446

Cat. No. M45160

All AbMole products are for research use only, cannot be used for human consumption.

LY3499446 Structure

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

LY3499446 is a KRAS G12C covalent inhibitor for studies related to non-small cell lung cancer (NSCLC).

Chemical Information
Molecular Weight 486.92
Formula C22H17ClF2N6OS
CAS Number 2409131-50-4
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Dipesh Uprety, et al. Cancer Treat Rev. KRAS: From undruggable to a druggable Cancer Target

[2] Misako Nagasaka, et al. Cancer Treat Rev. KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?

Related Ras Products
HH0043 

HH0043 is an orally active and potent SOS1 inhibitor, with IC50 value of 5.8 nM.

BI-2493 

BI-2493 is a structural analogue of BI-2865 and a highly selective and orally active pan-KRAS inhibitor.

D3S-001 

D3S-001 is an orally active inhibitor for KRAS.

MK-1084 

MK-1084 is a selective KRAS G12C inhibitor.

ADT-007 

ADT-007 is a potent and orally active pan-RAS inhibitor with strong anticancer effects.

  Catalog
Abmole Inhibitor Catalog




Keywords: LY3499446 supplier, Ras, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.